查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1609671

2024-2032 年日本数位病理学市场报告（按产品、类型、交付模式、应用、最终用户和地区）

Japan Digital Pathology Market Report by Product, Type, Delivery Model, Application, End User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2023年日本数位病理IMARC Group规模达3,611万美元。主要参与者对医疗保健技术的广泛投资主要推动了市场的成长。

数位病理学是一种尖端医疗技术，彻底改变了检查组织样本进行疾病诊断的传统做法。数位病理学不使用传统的玻片，而是将组织样本数位化为高解析度影像。然后以电子方式储存、分析和共享这些数位影像，使病理学家和医疗专业人员能够远端协作和诊断。数位病理学具有许多优势，包括提高诊断癌症等疾病的准确性、速度和效率。它还促进人工智慧和机器学习演算法的集成，有助于实现影像分析某些方面的自动化并提高诊断精度。此外，数位病理学可以创建广泛的数位檔案，使研究人员能够存取和研究用于各种目的的大量医疗资料储存库，包括医学研究、教育和医疗保健环境中的品质保证。

日本数位病理市场趋势：

日本的数位病理市场正在见证该国医疗保健领域的显着成长和转型。日本以其技术进步而闻名，正在将数位病理学作为加强疾病诊断和患者护理的强大工具。该技术的采用透过数位化病理切片简化了组织样本分析过程，允许病理学家之间进行远端协作并实现更快、更准确的诊断。随着人口老化的不断加剧，对精确、及时的病理服务的需求不断增加，这使得数位病理成为有效管理医疗保健需求的宝贵资产。此外，将人工智慧和机器学习整合到数位病理学系统中进一步增强了诊断能力。这些创新不仅提高了诊断准确性，还有助于解决该国病理学家短缺带来的挑战。随着日本继续投资医疗保健技术，数位病理市场预计将持续成长和创新，以满足医疗保健产业不断变化的需求。

日本数位病理学市场细分：

产品见解：

  • 扫描仪
  • 软体
  • 储存系统
  • 通讯系统

类型见解：

  • 人类病理学
  • 兽医病理学

交付模式见解：

  • 本地
  • 主办

应用见解：

  • 培训和教育
  • 咨询服务
  • 术中咨询
  • 常规诊断咨询服务
  • 其他的

最终使用者见解：

  • 製药和生物技术公司
  • 医院和参考实验室
  • 学术及研究机构

竞争格局：

市场研究报告也对竞争格局进行了全面分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

  • 日本数位病理市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本数位病理市场有何影响？
  • 日本数位病理市场依产品划分是怎样的？
  • 日本数位病理市场按类型划分是怎样的？
  • 日本数位病理市场在交付模式上的划分是怎么样的？
  • 日本数位病理市场在应用方面的细分如何？
  • 日本数位病理市场在最终用户方面的细分情况如何？
  • 日本数位病理市场价值链的各个阶段是什么？
  • 日本数位病理学的关键驱动因素和挑战是什么？
  • 日本数位病理市场的结构如何？
  • 日本数位病理市场的竞争程度如何？

本报告回答的关键问题：

  • 日本数位病理市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本数位病理市场有何影响？
  • 日本数位病理市场依产品划分是怎样的？
  • 日本数位病理市场按类型划分是怎样的？
  • 日本数位病理市场在交付模式上的划分是怎么样的？
  • 日本数位病理市场在应用方面的细分如何？
  • 日本数位病理市场在最终用户方面的细分情况如何？
  • 日本数位病理市场价值链的各个阶段是什么？
  • 日本数位病理学的关键驱动因素和挑战是什么？
  • 日本数位病理市场的结构如何？
  • 日本数位病理市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本数位病理市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本数位病理学市场格局

  • 历史与当前市场趋势（2018-2023）
  • 市场预测（2024-2032）

第 6 章：日本数位病理市场 - 细分：依产品分类

  • 扫描仪
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 软体
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 储存系统
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 通讯系统
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 7 章：日本数位病理市场 - 细分：按类型

  • 人类病理学
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 兽医病理学
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 8 章：日本数位病理市场 - 细分：按交付模式

  • 本地
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 主办
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 9 章：日本数位病理市场 - 细分：按应用分类

  • 培训和教育
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 咨询服务
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 术中咨询
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 常规诊断咨询服务
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 其他的
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 10 章：日本数位病理市场 - 细分：按最终用户划分

  • 製药和生物技术公司
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 医院和参考实验室
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）
  • 学术及研究机构
    • 概述
    • 历史与当前市场趋势（2018-2023）
    • 市场预测（2024-2032）

第 11 章：日本数位病理市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 12 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 13 章：日本数位病理市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 14 章：附录

简介目录
Product Code: SR112024A18022

Japan digital pathology market size reached US$ 36.11 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 118.34 Million by 2032, exhibiting a growth rate (CAGR) of 13.50% during 2024-2032. The widespread investments by key players in the healthcare technologies are primarily driving the market growth.

Digital pathology is a cutting-edge medical technology that revolutionizes the traditional practice of examining tissue samples for disease diagnosis. Instead of using conventional glass slides, digital pathology involves the digitization of tissue samples into high-resolution images. These digital images are then stored, analyzed, and shared electronically, enabling pathologists and medical professionals to collaborate and make diagnoses remotely. Digital pathology offers numerous advantages, including improved accuracy, speed, and efficiency in diagnosing diseases such as cancer. It also facilitates the integration of artificial intelligence and machine learning algorithms, which can assist in automating certain aspects of image analysis and enhancing diagnostic precision. Additionally, digital pathology allows for the creation of extensive digital archives, enabling researchers to access and study a vast repository of medical data for various purposes, including medical research, education, and quality assurance in healthcare settings.

Japan Digital Pathology Market Trends:

The digital pathology market in Japan is witnessing significant growth and transformation within the country's healthcare landscape. Japan, known for its technological advancements, is embracing digital pathology as a powerful tool to enhance disease diagnosis and patient care. The adoption of this technology streamlines the process of tissue sample analysis by digitizing pathology slides, allowing for remote collaboration among pathologists and enabling faster and more accurate diagnoses. With a growing aging population, the demand for precise and timely pathology services is increasing, making digital pathology an invaluable asset in managing healthcare needs efficiently. Additionally, the integration of artificial intelligence and machine learning into digital pathology systems is enhancing diagnostic capabilities further. These innovations not only improve diagnostic accuracy but also help address the challenges posed by a shortage of pathologists in the country. As Japan continues to invest in healthcare technologies, the digital pathology market is poised for continued growth and innovation to meet the evolving demands of the healthcare sector.

Japan Digital Pathology Market Segmentation:

Product Insights:

  • Scanners
  • Software
  • Storage Systems
  • Communication Systems

Type Insights:

  • Human Pathology
  • Veterinary Pathology

Delivery Model Insights:

  • On-premises
  • Hosted

Application Insights:

  • Training and Education
  • Consulting Services
  • Intraoperative Consultation
  • Routine Diagnostic Consultation Services
  • Others

End User Insights:

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Reference Laboratories
  • Academic and Research Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan digital pathology market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan digital pathology market?
  • What is the breakup of the Japan digital pathology market on the basis of product?
  • What is the breakup of the Japan digital pathology market on the basis of type?
  • What is the breakup of the Japan digital pathology market on the basis of delivery model?
  • What is the breakup of the Japan digital pathology market on the basis of application?
  • What is the breakup of the Japan digital pathology market on the basis of end user?
  • What are the various stages in the value chain of the Japan digital pathology market?
  • What are the key driving factors and challenges in the Japan digital pathology?
  • What is the structure of the Japan digital pathology market and who are the key players?
  • What is the degree of competition in the Japan digital pathology market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Digital Pathology Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Digital Pathology Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Digital Pathology Market - Breakup by Product

  • 6.1 Scanners
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Forecast (2024-2032)
  • 6.2 Software
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Forecast (2024-2032)
  • 6.3 Storage Systems
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)
  • 6.4 Communication Systems
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2018-2023)
    • 6.4.3 Market Forecast (2024-2032)

7 Japan Digital Pathology Market - Breakup by Type

  • 7.1 Human Pathology
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Veterinary Pathology
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)

8 Japan Digital Pathology Market - Breakup by Delivery Model

  • 8.1 On-premises
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Forecast (2024-2032)
  • 8.2 Hosted
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Forecast (2024-2032)

9 Japan Digital Pathology Market - Breakup by Application

  • 9.1 Training and Education
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Consulting Services
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Intraoperative Consultation
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)
  • 9.4 Routine Diagnostic Consultation Services
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2018-2023)
    • 9.4.3 Market Forecast (2024-2032)
  • 9.5 Others
    • 9.5.1 Historical and Current Market Trends (2018-2023)
    • 9.5.2 Market Forecast (2024-2032)

10 Japan Digital Pathology Market - Breakup by End User

  • 10.1 Pharmaceutical and Biotechnology Companies
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2018-2023)
    • 10.1.3 Market Forecast (2024-2032)
  • 10.2 Hospitals and Reference Laboratories
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2018-2023)
    • 10.2.3 Market Forecast (2024-2032)
  • 10.3 Academic and Research Institutes
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2018-2023)
    • 10.3.3 Market Forecast (2024-2032)

11 Japan Digital Pathology Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Digital Pathology Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix